You are here

Article Text

Article menu

Download PDFPDF

Miscellaneous
Interstitial lung disease and leflunomide use
Free
  1. V Aiyappan
  1. Senior House Office, Huddersfield Royal Infirmary, Huddersfield, UK; aiyapps@yahoo.com

https://doi.org/10.1136/thx.2006.la0224

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    ▴ Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum2006;54:1435–9
    OpenUrlCrossRefPubMedWeb of Science

    There have been numerous reports of interstitial lung disease associated with the use of the new disease modifying anti-rheumatic drug leflunomide. This epidemiological study examined the risk of developing interstitial …

    View Full Text